Outcome of 5-Azacitidine and Decitabine Treatment in Elderly Patients with Myelodysplastic Syndrome

被引：0
|
作者：
Nam, Seung-Hyun [1 ]
Lim, Taekyu [1 ]
Kim, Bong-Seog [1 ]
机构：
[1] VHS Med Ctr, Seoul, South Korea
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.4959.4959
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4959
引用
收藏
页数：1
相关论文
共 50 条
  • [1] OUTCOME OF 5-AZACITIDINE AND DECITABINE TREATMENT IN ELDERLY PATIENTS WITH MYELODYSPLASTIC SYNDROME
    Nam, S.
    Lim, T.
    Kim, B.
    HAEMATOLOGICA, 2013, 98 : 588 - 588
  • [2] Head-to-head comparison of 5-azacitidine versus decitabine for the treatment of myelodysplastic syndrome
    Kim, I.
    Lee, Y. G.
    Yoon, S. S.
    Park, S.
    Cheong, J. W.
    Min, Y. H.
    Bang, S. M.
    Kim, C. S.
    Park, Y.
    Mun, Y. C.
    Seong, C. M.
    Park, J.
    Lee, J. H.
    Lee, H. G.
    Kim, Y. K.
    Kim, H. J.
    LEUKEMIA RESEARCH, 2013, 37 : S17 - S17
  • [3] Head-to-Head Comparison of 5-Azacitidine Versus Decitabine for the Treatment of Myelodysplastic Syndrome
    Lee, Yun-Gyoo
    Kim, Inho
    Yoon, Sung-Soo
    Park, Seonyang
    Cheong, June-Won
    Min, Yoo-Hong
    Bang, Soo-Mee
    Kim, Chul Soo
    Park, Yong
    Mun, Yeung Chul
    Park, Jinny
    Lee, Jae Hoon
    Lee, Hong Ghi
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    BLOOD, 2012, 120 (21)
  • [4] Decitabine versus 5-azacitidine for the treatment of myelodysplastic syndrome: adjusted indirect meta-analysis
    Kumar, Ambuj
    List, Alan F.
    Hozo, Iztok
    Komrokji, Rami
    Djulbegovic, Benjamin
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (02): : 340 - 342
  • [5] DNA Methylation Changes Following 5-azacitidine Treatment in Patients with Myelodysplastic Syndrome
    Huong Thi Thanh Tran
    Kim, Hee Nam
    Lee, Il-Kwon
    Kim, Yeo-Kyeoung
    Ahn, Jae-Sook
    Yang, Deok-Hwan
    Lee, Je-Jung
    Kim, Hyeoung-Joon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (02) : 207 - 213
  • [6] DNA Methylation Changes Following 5-Azacitidine Treatment in Patients with Myelodysplastic Syndrome
    Tran, Huong Thi Thanh
    Kim, Hee Nam
    Kim, Yeo-Kyeoung
    Ahn, Jae-Sook
    Lee, Il-Kwon
    Yang, Deok-Hwan
    Lee, Je-Jung
    Hoon, Kook
    Hwang, Tai Ju
    Kim, Hyeoung-Joon
    BLOOD, 2009, 114 (22) : 1091 - 1092
  • [7] Repeated responses of an elderly patient with high-risk myelodysplastic syndrome to sequential therapy with tipifarnib, 5-azacitidine, and decitabine
    Isabel Möller
    Sabine Blum
    Norbert Gattermann
    Rainer Haas
    Kerstin Habersang
    Ulrich Germing
    Andrea Kuendgen
    Annals of Hematology, 2009, 88 : 1141 - 1144
  • [8] Repeated responses of an elderly patient with high-risk myelodysplastic syndrome to sequential therapy with tipifarnib, 5-azacitidine, and decitabine
    Moeller, Isabel
    Blum, Sabine
    Gattermann, Norbert
    Haas, Rainer
    Habersang, Kerstin
    Germing, Ulrich
    Kuendgen, Andrea
    ANNALS OF HEMATOLOGY, 2009, 88 (11) : 1141 - 1144
  • [9] IMPACT OF COMORBIDITY ON TREATMENT WITH 5-AZACITIDINE AND OUTCOME IN 39 PATIENTS WITH MYELODYSPLASTIC SYNDROME: A SINGLE CENTER POPULATION ANALYSIS
    Castelli, M.
    Binotto, G.
    Pavanello, F.
    Ermani, M.
    Zambello, R.
    Semenzato, G.
    HAEMATOLOGICA, 2012, 97 : 586 - 586
  • [10] Treatment outcome of 5′-azacitidine for myelodysplastic syndrome
    Kim, Y. K.
    Kim, H. J.
    Song, J. E.
    Kim, S. E.
    Ahn, J. S.
    Yang, D. H.
    Lee, J. J.
    LEUKEMIA RESEARCH, 2013, 37 : S110 - S110
12345